Introduction: Closely related plant species often share similar secondary metabolites and bioactivities and are therefore good targets for bioactivity testing when one or more species within a genus are known to possess therapeutic properties. The genus Eucalyptus has a long history of medicinal usage by the first Australians. Many species are known to have therapeutic properties, several species of which have well established antibacterial bioactivities. Methods: The ability of Eucalyptus grandis leaf and flower extracts to inhibit the growth of a panel of bacterial and fungal pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: E. grandis leaf and flower methanolic and aqueous extracts were completely ineffective at inhibiting the growth of gram-positive and gram-negative panels of bacteria, as well as fungi. The extracts were nontoxic in the Artemia nauplii bioassay following 24 hr exposure. Conclusion: Despite the taxonomic relationship to several bioactive Eucalyptus spp., E. grandis leaf and flower extracts were completely ineffective bacterial and fungal growth inhibitors. However, these extracts may have other therapeutic properties and testing against protozoa, virus and tumour cells is required.
INTRODUCTION
Traditional plant derived medicines have been used in most parts of the world for a variety of therapeutic purposes, including fighting microbial disease. Indeed, the ability of plant extracts to block the growth of pathogenic bacteria has become a focus of substantial recent study. [1] [2] [3] [4] [5] Much of the research into traditional medicinal plant use has focused on Asian, [6] [7] [8] African, [9] [10] [11] Middle Eastern [12] [13] [14] and South American 15 plants. However, despite the potential of plants to provide us with useful pharmaceutical agents, the field is still relatively poorly studied. Only an estimated 5-10 % of the approximately 300,000-500,000 plant species worldwide have been screened for one or more bioactivities. 9 With so many plant species yet to be tested, it is essential that plant selection processes narrow the field. The main selection criteria currently used is to select plants on the basis of ethnobotanical usage as traditional medicines. Another important selection method is to examine plants related to species for which medicinal potential is well established. Many plant secondary metabolites are regarded as family, genus or species specific and investigation of species closely related to those used as traditional medicines may lead to natural therapeutic discoveries. 16 The development of new antibiotic therapies is particularly urgent. The recent establishment of bacterial pathogens that are either extremely (XDR) or totally resistant (TDR) to common clinically used antibiotics 17 has resulted in the need to develop new and effective antibiotic chemotherapies. There are now limited therapeutic options for many diseases caused by bacterial pathogens and the situation is expected to worsen in the future as bacteria exchange resistance genes. Indeed, the development of alternative antibacterial treatment modalities has become crucial and is considered by the World Health Organisation (WHO) to be one of the most serious challenges facing medical science. 18 For a number of reasons reviewed elsewhere, 17 it is unlikely that the previous methods of antibiotic discovery/development will be as successful in the future and new treatment modalities are urgently required. Traditional medicines and herbal remedies have great potential for antimicrobial drug development and there has recently been a substantial increase in interest in this field. 19, 20 The first Australians had well-developed medicinal systems and understood the therapeutic properties of a wide variety of Australian plants and how to use them effectively. 16 Despite this, relatively few studies have rigorously examined the antibacterial activity of Australian native plants, although there has recently been a substantial increase in interest in this field. [21] [22] [23] [24] The genus Eucalyptus (family Myrtaceae) consists of more than 700 species of trees and shrubs, with the majority native to Australia. 25 Eucalyptus grandis W. Hill. ex Maiden (commonly known as rose gum or flooded gum) is an endemic Australian tree ( Figure 1a ) that grows in coastal regions of Eastern Australia from the Sydney region northwards to central Queensland. It is a large tree and grows to approximately 50 metres, although some specimens can exceed 80 metres high. Its long straight trunk is valued by the timber and pulp industries and extensive plantations have been established internationally, particularly in South Africa and Brazil. The glossy green leaves (10-16cm long by 2-3cm wide) are lanceolate and paler on the undersides (Figure 1b ). White flowers ( Figure 1b ) appear in mid-autumn to late winter and develop into small (6mm by 5mm) cone shaped gumnuts with protruding valves ( Figure  1c ). Many Eucalyptus spp., were used by the first Australians for their antiseptic properties 16, 26 and the efficacy has been verified for several species in laboratory studies. 27 In contrast, there is less evidence that E. grandis was used medicinally by the first Australians and relatively few studies have tested the antibiotic properties of this species. A recent study reported potent growth inhibitory activity for essential oils produced from E. grandis leaves against a broad panel of pathogenic bacteria, including many of the same species tested in our study. 28 However, that study tested high concentration of essential oils and reported MIC values of ≥10mg/mL against many of the bacterial species tested. It is noteworthy that these MICs would be classified as inactive in many test systems. Furthermore, there may be doubts about the results of this study as the MIC values reported for the standard drug ampicillin against these bacteria was similar to that reported for the essential oils (i.e. ≥10mg/mL), even against ampicillin sensitive bacterial strains. We were unable to find any studies examining the antibacterial activity of solvent extractions. The phytochemical composition of E. grandis is also relatively poorly studied. However, one recent study identified β-sitosterol ( Figure 1d ), syringaldehyde ( Figure 1e ), catechin (Figure 1f ), proanthocyanidin dimer (Figure 1g ), ellagic acid ( Figure 1h ) and ellagic acli-O-pentoside ( Figure 1i ) in E. grandis wood. 29 Phytochemical evaluations of the other parts of this species are less extensive and much further work is required. Many of these compounds have been reported to have potent antibacterial activity 30 and may therefore contribute to the antibacterial properties of E. grandis. This study was undertaken to screen E. grandis leaf and flower extracts for the ability to inhibit the growth of a panel of gram-positive and gram-negative bacterial pathogens and three fungi.
MATERIALS AND METHODS

Plant material
Collection of plant material and extraction
Eucalyptus grandis W. Hill ex Maiden leaves and flowers were obtained from and identified by Philip Cameron, senior botanic officer, Mt Cootha Botanical Gardens, Brisbane, Australia. The harvested leaves and flowers were washed in deionised water and processed within 4 hr of collection. The leaves were dried in a Sunbeam food dehydrator and the dried material was ground to a coarse powder. Individual 1g masses of the dried plant material was extracted extensively in 50mL methanol (Ajax, AR grade) or deionised water for 24 hr at 4°C with gentle shaking. The extract was filtered through filter paper (Whatman No. 54) under vacuum followed by drying by rotary evaporation. The resultant pellet was dissolved in 5mL deionised water. The extract was passed through 0.22µm filter (Sarstedt) and stored at 4°C.
Qualitative phytochemical studies
Phytochemical analysis of the E. grandis leaf and flower extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by standard assays. [31] [32] [33] Antibacterial screening 
Evaluation of antimicrobial activity
Antimicrobial activity of the E. grandis leaf and flower extracts was determined using a modified disc diffusion assay. [34] [35] [36] Briefly, 100µL of the each microbial suspension in log phase was spread onto individual nutrient agar plates (or Sabour and agar for the fungal strains) and the extracts were tested for antimicrobial activity using 6mm sterilised filter paper discs. The discs were each infused with 10µL of the individual plant extract, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2hr before incubation at 37°C for 24hr. The diameters of the zones of inhibition (ZOIs) were measured to the closest whole millimetre. Each assay was performed three times in triplicate (n=9). Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10µg), chloramphenicol (10µg) and nystatin (100µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial and antifungal activity. Filter discs infused with 10µL of distilled water were used as a negative control.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [37] [38] [39] Briefly, A. franciscana nauplii were incubated in the presence of the extracts, reference toxin (1mg/mL potassium dichromate) or artificial seawater (negative control) at 25±1°C under artificial light. All treatments were performed three times in triplicate (n=9). The number of dead were counted in each well at 24hr, 48hr and 72hr. At the completion of the 72hr exposure period, the remaining live nauplii were sacrificed and the total number of nauplii in each well were counted and used to calculate the % mortality per well. LC 50 values were calculated for each treatment using probit analysis.
Statistical analysis
Data are expressed as the mean ± SEM of three independent experiments with internal triplicates (n=9). One-way ANOVA was used to calculate statistical significance between control and treated groups, with a P value <0.01 considered to be statistically significant.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1g of dried and powdered E. grandis leaves and flowers with methanol and water yielded 242 (aqueous leaf extract) to 348mg (methanolic flower extract) of extracted material respectively (Table 1) . Methanol was a better extractant, resulting in higher yield of extracted material compared to water. Additionally, the flowers had higher extraction yields than the leaf extracts. The extracts were resuspended in 10mL of deionised water (containing 1% DMSO), resulting in the extract concentrations shown in Table 1 . Qualitative phytochemical studies showed that both leaf extracts had similar phytochemical profiles. Both contained high levels of phenolic compounds and flavonoids, as well as moderate levels of saponins and low levels of triterpenoids. The flower extracts also had similar phytochemical profiles to the leaf extracts.
Antimicrobial activity
To determine the growth inhibitory activity of the E. grandis leaf and flower extracts, aliquots (10µL) of each extract were screened in the disc diffusion assay. The E. grandis leaf and flower extracts were ineffective at inhibiting the growth of all gram-negative ( Figure 2 ) and gram positive ( Figure 3 ) bacterial species tested. In contrast, both positive control antibiotics (ampicillin and chloramphenicol) were effective growth inhibitors, with ZOI's of up to 14.3mm (chloramphenicol against E. coli). We were therefore unable to determine the MIC values for any extract as they were completely ineffective at all concentrations tested. Similarly, all of the extracts were ineffective at inhibiting the growth of the three fungal species screened in this study (Figure 4 ).
Quantification of Toxicity
The toxicity of the E. grandis leaf and flower extracts was initially tested at 1000µg/mL in the A. franciscana nauplii bioassay ( Figure 5 ). The mortality in the presence of all extracts was substantially <1000µg/mL at 24h and thus all extracts were deemed to be non-toxic. Extracts with 24h LC 50 values >1000µg/mL have previously been defined as non-toxic. 39 In contrast, the potassium dichromate positive control induced substantial mortality within 4hr (results not shown), with 100% mortality induction seen by 24hr. The mortality increased following exposure to the E. grandis leaf extracts at 48hr and was further increased following 72hr exposure.
DISCUSSION
Due to recent increases in bacterial resistance to many antibiotics, the development of new antibiotic chemotherapies is a high priority for medical science. 17, 18 A concurrent decrease in the discovery of new antibiotic medicines by conventional strategies has increased interest in re-evaluating medicinal plants for new antibiotic chemotherapies. 40 Whilst we were unable to find reports of the traditional use of E. grandis medicinally, it is taxonomically related to other Eucalyptus spp. with extensive therapeutic uses. Indeed, Lassak and McCarthy 26 43 Interestingly, several recent studies have reported that the antibacterial activity of some Eucalyptus spp. may require the action of endophytic fungi associated with the leaves. 44, 45 It is possible that the E. grandis leaves examined in our study may not harbour these endophytes and this may result in the lack of activity seen in this study. Future studies are required to identify which (if any) fungal endophytes are associated with E. grandis leaves. A single assay technique was used to screen for antibacterial activity in this study (as well as in the previous studies examining the antibacterial activity of this species). We chose to use the disc diffusion assay as it is a rapid method and it has previously been widely utilised in other studies. Therefore, comparisons between studies are relatively simple. However, as the disc diffusion method is reliant on the diffusion of a molecule through the aqueous environment of an agar gel, this assay may be affected by the solubility of the extract compounds in the aqueous environment. Polar compounds that are highly soluble in water would be expected to diffuse easily in the gel, whereas less soluble compounds would not diffuse as readily and thus be concentrated around the disc. Diffusion of molecules within an agar gel is also affected by the size of the molecules. The movement of large, complex phytochemicals (e.g. triterpenoids) through agar gels by diffusion would also be retarded and may provide a false idea of the efficacy of an extract. As many triterpenoids have well described antibiotic properties, screening for growth inhibition using agar diffusion techniques may give a fallacious view of its inhibitory potential. For this reason, whilst this is a handy assay for screening aqueous extracts, this technique may not be ideal for nonpolar compounds. For examining nonpolar mixtures, other techniques such as liquid dilution assays may be preferred. As Eucalyptus spp. are known to contain nonpolar terpenoid components, 29 their activity may have been significantly underestimated. Liquid dilution studies may have been better suited to screen E. grandis extracts for activity and future studies will use these techniques to re-examine the extracts for antibacterial activity. The findings reported here also indicate that the extracts examined were non-toxic (24 hr LC 50 >1000 µg/mL) in the Artemia nauplii bioassay. Whilst toxicity was assessed in this study with the test organism A. franciscana, toxicity towards A. franciscana has previously been shown to correlate well with toxicity towards human cells for many toxins. 39 However, further studies are required to determine whether this is also true for the E. grandis leaf extracts examined in these studies.
CONCLUSION
Methanolic and aqueous E. grandis leaf and flower extracts displayed no antibacterial activity in the disc diffusion assay against panels of human pathogenic bacteria and fungi, despite their close taxonomic relationship with other Eucalyptus spp. with well-known antibacterial properties. The extracts were nontoxic towards Artemia nauplii.
• E. grandis leaf and flower extracts were screened for the ability to block the growth of a panel of human bacterial pathogens.
• No inhibitory activity was evident against any of the bacterial species tested.
• Toxicity of the E. grandis extracts was determined using the Artemia nauplii toxicity bioassay.
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